Infectious Disease Alert – June 1, 2013
June 1, 2013
View Issues
-
Uncomplicated Pure Cellulitis: No Need to Cover for MRSA?
Uncomplicated cellulitis, defined as cellulitis without abscess, is most often caused by streptococci. -
Infectious Disease Alert Survey Now Online
Infectious Disease Alert Survey Now Online! -
Zoster Vaccine Works — If People Get It
In a 5% random Medicare sample to examine the uptake and efficacy of the herpes zoster vaccine in the general population, including immunocompromised individuals — the adjusted vaccine efficacy for protection against herpes zoster was 0.48 (95% CI, 0.39 to 0.56). -
Leptin may Mediate Severe Infection in Obese Patients with Pandemic Influenza A
High levels of circulating leptin contribute to the development of severe lung injury by Influenza A(H1N1) pdm09 in mice with diet-induced obesity. -
Inhibition of Telomerase Activity by NRTI’s may Contribute to Accelerated Aging in HIV Patients
Nucleoside and nucleotide analogues inhibit telomerase activity and leads to shortening of telomere length (TL) in activated PBMC’s in culture. -
Coccidioidomycosis – Update
In the last issue of Infectious Disease Alert, we summarized a recent report demonstrating the increasing risk of coccidioidomycosis, especially in California and Arizona. The comment ended by pointing out the large number of cases of this fungal infection that occurred during construction of Interstate 5... -
Is Your Smart Phone Spreading Infection in the ICU?
Bacteria were present on the cell phones of all hospital clinicians studied, with potentially pathogenic microorganisms isolated from 29% of them. Contamination with pathogens was found more commonly with smart phones than with non-smart phones, and by multivariable analysis no other factor was associated with this difference. -
Updates
Risk of TB in older persons; Non-cocci cocci; A new “App” for your mobile phone -
Pharmacology Watch: Do Perioperative Beta-Blockers Reduce Mortality?
Perioperative beta-blockers; Medication use and pregnancy; Discontinuation of statins; FDA actions -
Clinical Briefs in Primary Care supplement